Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma

Conclusion: Inhibition of CSF-1R improved response to RT in the treatment of GBM and may represent a promising strategy to improve RT-induced antitumor immune responses.

Source: In Vivo - January 5, 2021 Category: Research Authors: ALMAHARIQ, M. F., QUINN, T. J., KESARWANI, P., KANT, S., MILLER, C. R., CHINNAIYAN, P. Tags: Experimental Studies Source Type: research